These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes. Deeb O; Goodarzi M; Khadikar PV Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786 [TBL] [Abstract][Full Text] [Related]
28. Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin. Jiang H; Chen K; Tang Y; Chen J; Li Q; Wang Q; Ji R J Med Chem; 1997 Sep; 40(19):3085-90. PubMed ID: 9301672 [TBL] [Abstract][Full Text] [Related]
29. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
30. QSAR modeling of AT1 receptor antagonists using ANN. Su Q; Zhou L J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251 [TBL] [Abstract][Full Text] [Related]
31. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions. Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033 [TBL] [Abstract][Full Text] [Related]
32. Structural bioinformatics and QSAR analysis applied to the acetylcholinesterase and bispyridinium aldoximes. Mager PP; Weber A Drug Des Discov; 2003; 18(4):127-50. PubMed ID: 15553925 [TBL] [Abstract][Full Text] [Related]
33. 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors. Sheng C; Zhu J; Zhang W; Zhang M; Ji H; Song Y; Xu H; Yao J; Miao Z; Zhou Y; Zhu J; Lü J Eur J Med Chem; 2007 Apr; 42(4):477-86. PubMed ID: 17349719 [TBL] [Abstract][Full Text] [Related]
34. Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA. Mena-Ulecia K; Tiznado W; Caballero J PLoS One; 2015; 10(11):e0142774. PubMed ID: 26599107 [TBL] [Abstract][Full Text] [Related]
35. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM). Peng T; Pei J; Zhou J J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565 [TBL] [Abstract][Full Text] [Related]
36. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets. Murcia M; Morreale A; Ortiz AR J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130 [TBL] [Abstract][Full Text] [Related]
37. Compounds binding to the S2-S3 pockets of thrombin. Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038 [TBL] [Abstract][Full Text] [Related]
38. Non-linear quantitative structure-activity relationship for adenine derivatives as competitive inhibitors of adenosine deaminase. Sadat Hayatshahi SH; Abdolmaleki P; Safarian S; Khajeh K Biochem Biophys Res Commun; 2005 Dec; 338(2):1137-42. PubMed ID: 16256072 [TBL] [Abstract][Full Text] [Related]
39. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors. Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163 [TBL] [Abstract][Full Text] [Related]
40. In silico Prediction of Inhibitory Constant of Thrombin Inhibitors Using Machine Learning. Zhao J; Zhu L; Zhou W; Yin L; Wang Y; Fan Y; Chen Y; Liu H Comb Chem High Throughput Screen; 2018; 21(9):662-669. PubMed ID: 30569853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]